Recent 13F filings as of December 2025 show that 128 institutional investors hold a position in Aldeyra Therapeutics, Inc. (NASDAQ:ALDX).
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| Knoll Capital Management, LLC | 31 Dec, 2025 | 5,475,516 | 0 | 0.00% | $28,363,172.00 |
| PERCEPTIVE ADVISORS LLC | 31 Dec, 2025 | 4,185,632 | -1,036,679 | -19.85% | $21,681,574.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 3,850,103 | 45,183 | 1.19% | $19,943,533.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 3,698,682 | 106,813 | 2.97% | $19,159,173.00 |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 31 Dec, 2025 | 1,850,000 | 518,209 | 38.91% | $9,583,000.00 |
| D. E. Shaw & Co., Inc. | 31 Dec, 2025 | 1,601,324 | 221,481 | 16.05% | $8,294,858.00 |
| 683 Capital Management, LLC | 31 Dec, 2025 | 1,530,000 | 710,000 | 86.59% | $7,925,400.00 |
| ARDSLEY ADVISORY PARTNERS LP | 31 Dec, 2025 | 1,450,000 | -450,000 | -23.68% | $7,511,000.00 |
| KENNEDY CAPITAL MANAGEMENT LLC | 31 Dec, 2025 | 1,255,838 | 143,625 | 12.91% | $6,505,241.00 |
| AQR CAPITAL MANAGEMENT LLC | 31 Dec, 2025 | 1,226,922 | -278,438 | -18.50% | $6,355,456.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 1,170,537 | -5,883 | -0.50% | $6,064,616.00 |
| STATE STREET CORP | 31 Dec, 2025 | 1,098,600 | -4,074 | -0.37% | $5,690,748.00 |
| ACADIAN ASSET MANAGEMENT LLC | 31 Dec, 2025 | 979,521 | 143,710 | 17.19% | $5,071.00 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 31 Dec, 2025 | 968,751 | 21,200 | 2.24% | $5,018,130.00 |
| MORGAN STANLEY | 31 Dec, 2025 | 657,032 | -426,287 | -39.35% | $3,403,426.00 |
| DIMENSIONAL FUND ADVISORS LP | 31 Dec, 2025 | 612,258 | -36,113 | -5.57% | $3,171,391.00 |
| BANK OF AMERICA CORP /DE/ | 31 Dec, 2025 | 410,028 | 19,950 | 5.11% | $2,123,946.00 |
| JANE STREET GROUP, LLC | 31 Dec, 2025 | 383,352 | 97,634 | 34.17% | $1,985,764.00 |
| NORTHERN TRUST CORP | 31 Dec, 2025 | 379,405 | -28,555 | -7.00% | $1,965,318.00 |
| WELLS FARGO & COMPANY/MN | 31 Dec, 2025 | 366,169 | 4,700 | 1.30% | $1,896,755.00 |